Your browser doesn't support javascript.
loading
Primary follicular lymphoma of the prostate presenting with elevated PSA and a PI-RADS 3 lesion on MRI: A case report.
Jia, Hanna; Roberson, Daniel; Luo, Xunda; Kovell, R Caleb; Hartner, Lee; Harryhill, Joseph F.
Afiliación
  • Jia H; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Roberson D; Division of Urology, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Luo X; Department of Pathology and Laboratory Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Kovell RC; Division of Urology, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Hartner L; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Harryhill JF; Division of Urology, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
Urol Case Rep ; 45: 102195, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36105544
Prostate cancer is the most common malignancy diagnosed in men. PI-RADS 3 lesions on multiparametric MRI, when histologically proven malignant, overwhelmingly represent prostatic adenocarcinoma. Primary lymphoma of the prostate, especially follicular lymphoma, is exceedingly rare. To our knowledge, its presentation with a PI-RADS 3 lesion and elevated PSA has not been previously described. We report the case of a 68-year-old, healthy male presenting with elevated PSA and lower urinary tract symptoms found to have a PI-RADS 3 lesion. Prostate biopsy revealed low-grade follicular lymphoma, and staging showed no other lesions. The patient is currently being managed with close surveillance.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Urol Case Rep Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Urol Case Rep Año: 2022 Tipo del documento: Article